Commodore Capital LP Diversified Active

Location: New York, NY

CIK: 0001831942 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value: $657M (100.0% shares, 0.0% debt)

Holdings (32)

XENE XENON PHARMACEUTICALS INC 10.1%

Value $66.03M Shares 1,845,000 Est. Cost $26.06 Unrealized +41.8%

VRDN VIRIDIAN THERAPEUTICS INC 8.5%

Value $55.7M Shares 2,189,659 Est. Cost $17.59 Unrealized +82.3%

— MERUS N V 8.3%

Value $54.28M Shares 2,950,000 Est. Cost $24.72 Unrealized —

COGT COGENT BIOSCIENCES INC 7.8%

Value $51.49M Shares 4,772,421 Est. Cost $8.50 Unrealized +50.5%

— BELLUS HEALTH INC NEW 7.2%

Value $47.37M Shares 6,579,359 Est. Cost $7.78 Unrealized —

— AMBRX BIOPHARMA INC 6.5%

Value $42.85M Shares 4,803,447 Est. Cost $8.92 Unrealized —

ELVN ENLIVEN THERAPEUTICS INC 5.8%

Value $37.92M Shares 1,731,365 Est. Cost $20.34 Unrealized 0.0%

— AKERO THERAPEUTICS INC 4.6%

Value $30.23M Shares 790,000 Est. Cost $35.40 Unrealized —

NUVL NUVALENT INC 4.3%

Value $28.05M Shares 1,075,000 Est. Cost $28.14 Unrealized +5.1%

IMVT IMMUNOVANT INC 3.4%

Value $22.35M Shares 1,440,999 Est. Cost $13.55 Unrealized +28.1%

VERA VERA THERAPEUTICS INC 3.3%

Value $21.91M Shares 2,824,029 Est. Cost $7.72 Unrealized 0.0%

SNDX SYNDAX PHARMACEUTICALS INC 2.7%

Value $18.03M Shares 853,884 Est. Cost $22.91 Unrealized +8.6%

CLDX CELLDEX THERAPEUTICS INC NEW 2.7%

Value $17.84M Shares 495,823 Est. Cost $30.35 Unrealized +42.2%

— CYMABAY THERAPEUTICS INC 2.7%

Value $17.66M Shares 2,025,000 Est. Cost $4.40 Unrealized —

CABA CABALETTA BIO INC 2.3%

Value $15.18M Shares 1,835,000 Est. Cost $6.21 Unrealized +50.7%

KURA KURA ONCOLOGY INC 2.2%

Value $14.74M Shares 1,204,958 Est. Cost $14.26 Unrealized -12.5%

ARWR ARROWHEAD PHARMACEUTICALS IN 2.2%

Value $14.61M Shares 575,000 Est. Cost $36.39 Unrealized -13.6%

CELC CELCUITY INC 2.2%

Value $14.26M Shares 1,390,772 Est. Cost $20.36 Unrealized -46.2%

— PROMETHEUS BIOSCIENCES INC 2.1%

Value $13.65M Shares 127,156 Est. Cost $110.00 Unrealized —

— ALPINE IMMUNE SCIENCES INC 1.6%

Value $10.23M Shares 1,325,000 Est. Cost $7.20 Unrealized —

DAWN DAY ONE BIOPHARMACEUTICALS I 1.5%

Value $9.889M Shares 739,661 Est. Cost $10.33 Unrealized +89.2%

RNAM AVIDITY BIOSCIENCES INC 1.4%

Value $9.067M Shares 590,705 Est. Cost $14.91 Unrealized +47.6%

ENTA ENANTA PHARMACEUTICALS INC 1.3%

Value $8.786M Shares 217,253 Est. Cost $51.53 Unrealized -7.3%

— ALLAKOS INC 1.3%

Value $8.455M Shares 1,900,000 Est. Cost $5.89 Unrealized —

PCVX VAXCYTE INC 1.1%

Value $7.496M Shares 200,000 Est. Cost $39.66 Unrealized +6.9%

ACRS ACLARIS THERAPEUTICS INC 0.8%

Value $5.137M Shares 635,000 Est. Cost $12.97 Unrealized -2.2%

— THIRD HARMONIC BIO INC 0.6%

Value $4.092M Shares 993,294 Est. Cost $18.97 Unrealized —

— ADVERUM BIOTECHNOLOGIES INC 0.5%

Value $3.587M Shares 5,000,000 Est. Cost $0.72 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 0.4%

Value $2.457M Shares 312,553 Est. Cost $24.62 Unrealized -69.7%

RZLT REZOLUTE INC 0.3%

Value $1.725M Shares 898,267 Est. Cost $3.32 Unrealized -32.3%

ABOS ACUMEN PHARMACEUTICALS INC 0.2%

Value $1.624M Shares 400,000 Est. Cost $5.74 Unrealized -8.9%

— DBV TECHNOLOGIES S A 0.0%

Value $157K Shares 92,687 Est. Cost $1.53 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
XENE	XENON PHARMACEUTICALS INC	1,845,000	$66.03M	10.1%	$26.06	+41.8%	COM	98420N105
VRDN	VIRIDIAN THERAPEUTICS INC	2,189,659	$55.7M	8.5%	$17.59	+82.3%	COM	92790C104
—	MERUS N V	2,950,000	$54.28M	8.3%	$24.72	—	COM	N5749R100
COGT	COGENT BIOSCIENCES INC	4,772,421	$51.49M	7.8%	$8.50	+50.5%	COM	19240Q201
—	BELLUS HEALTH INC NEW	6,579,359	$47.37M	7.2%	$7.78	—	COM NEW	07987C204
—	AMBRX BIOPHARMA INC	4,803,447	$42.85M	6.5%	$8.92	—	SPONSORED ADS	02290A102
ELVN	ENLIVEN THERAPEUTICS INC	1,731,365	$37.92M	5.8%	$20.34	0.0%	COM	29337E102
—	AKERO THERAPEUTICS INC	790,000	$30.23M	4.6%	$35.40	—	COM	00973Y108
NUVL	NUVALENT INC	1,075,000	$28.05M	4.3%	$28.14	+5.1%	COM	670703107
IMVT	IMMUNOVANT INC	1,440,999	$22.35M	3.4%	$13.55	+28.1%	COM	45258J102
VERA	VERA THERAPEUTICS INC	2,824,029	$21.91M	3.3%	$7.72	0.0%	CL A	92337R101
SNDX	SYNDAX PHARMACEUTICALS INC	853,884	$18.03M	2.7%	$22.91	+8.6%	COM	87164F105
CLDX	CELLDEX THERAPEUTICS INC NEW	495,823	$17.84M	2.7%	$30.35	+42.2%	COM NEW	15117B202
—	CYMABAY THERAPEUTICS INC	2,025,000	$17.66M	2.7%	$4.40	—	COM	23257D103
CABA	CABALETTA BIO INC	1,835,000	$15.18M	2.3%	$6.21	+50.7%	COM	12674W109
KURA	KURA ONCOLOGY INC	1,204,958	$14.74M	2.2%	$14.26	-12.5%	COM	50127T109
ARWR	ARROWHEAD PHARMACEUTICALS IN	575,000	$14.61M	2.2%	$36.39	-13.6%	COM	04280A100
CELC	CELCUITY INC	1,390,772	$14.26M	2.2%	$20.36	-46.2%	COM	15102K100
—	PROMETHEUS BIOSCIENCES INC	127,156	$13.65M	2.1%	$110.00	—	COM	74349U108
—	ALPINE IMMUNE SCIENCES INC	1,325,000	$10.23M	1.6%	$7.20	—	COM	02083G100
DAWN	DAY ONE BIOPHARMACEUTICALS I	739,661	$9.889M	1.5%	$10.33	+89.2%	COM	23954D109
RNAM	AVIDITY BIOSCIENCES INC	590,705	$9.067M	1.4%	$14.91	+47.6%	COM	05370A108
ENTA	ENANTA PHARMACEUTICALS INC	217,253	$8.786M	1.3%	$51.53	-7.3%	COM	29251M106
—	ALLAKOS INC	1,900,000	$8.455M	1.3%	$5.89	—	COM	01671P100
PCVX	VAXCYTE INC	200,000	$7.496M	1.1%	$39.66	+6.9%	COM	92243G108
ACRS	ACLARIS THERAPEUTICS INC	635,000	$5.137M	0.8%	$12.97	-2.2%	COM	00461U105
—	THIRD HARMONIC BIO INC	993,294	$4.092M	0.6%	$18.97	—	COM	88427A107
—	ADVERUM BIOTECHNOLOGIES INC	5,000,000	$3.587M	0.5%	$0.72	—	COM	00773U108
KALV	KALVISTA PHARMACEUTICALS INC	312,553	$2.457M	0.4%	$24.62	-69.7%	COM	483497103
RZLT	REZOLUTE INC	898,267	$1.725M	0.3%	$3.32	-32.3%	COM NEW	76200L309
ABOS	ACUMEN PHARMACEUTICALS INC	400,000	$1.624M	0.2%	$5.74	-8.9%	COM	00509G209
—	DBV TECHNOLOGIES S A	92,687	$157K	0.0%	$1.53	—	SPONSORED ADR	23306J101